.
Asthma and COPD medication adherence was lowest in young adults, highest in children and older adults MADISON, Wisc., January 26, 2021 – Adherence to asthma and COPD...
Patients also used their rescue inhalers less often with the help of a digital health tool, according to new research MADISON, Wisc., November 19, 2020 – Patients using...
Patients in Japan using Enerzair® and Atectura® Breezhaler® to treat uncontrolled asthma will now have access to Propeller’s digital health platform through their...
Enerzair® Breezhaler® plus sensor is the first asthma medication to be co-packaged and co-prescribed with a digital health platform MADISON, Wisc., July 7, 2020 –...
The sensor, part of the 510(k) clearance, was developed in partnership with AstraZeneca MADISON, Wis.--Propeller Health, a leading digital health company dedicated to the...
MADISON, Wis. & CHICAGO -- New data from digital inhalers confirms that exposure to the air pollutant ozone is strongly linked to increased use of inhaled medications for...
Propeller is the only digital health solution for chronic respiratory disease to be included in the first release of the formulary, which will help people with chronic...
Patients with chronic obstructive pulmonary disease (COPD) at Louisville’s JenCare Senior Medical Center, a ChenMed company, saw their health outcomes improve significantly...
With the expansion of the My Pharmacy feature, patients can use Propeller to refill prescriptions with five of the seven largest pharmaceutical providers in the...
My Propeller
Propeller Logo
